The addition of apalutamide to androgen deprivation therapy before and after surgery improved outcomes among men with ...
Radical prostatectomy is potentially curative in patients with high-risk localized or locally advanced prostate cancer; however, relapse occurs within 5 years in up to 50% of patients. We ...
Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization of innovative positron emission tomography (PET) radiopharmaceuticals, today announced that nine ...
Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment Screening for prostate cancer with a blood test can save men’s lives, but the “absolute ...
Prostate cancer is the most common cancer to affect American men, besides skin cancer. The American Cancer Society estimates that 1 in 8 men will be diagnosed with prostate cancer at some point in ...
New indication authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) expands access to lutetium177 vipivotide tetraxetan in the UK for eligible mCRPC patients earlier in the ...
1. In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while accounting for other-cause mortality (OCM). 2. This model more accurately ...
Photothermal performance was evaluated by irradiating nanoparticle dispersions (0–0.2 mg/mL) with an 808 nm NIR laser (MDL-808-5W, 1.0 W/cm 2, 5 min) while recording real-time temperature changes ...
Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being ...
The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for prostate-specific antigen, known as a PSA test. The IsoPSA blood test, developed by ...
DEAR DR. ROACH: I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results